Page 500 - Read Online

Pastor et al. J Cancer Metastasis Treat 2020;6:39 I http://dx.doi.org/10.20517/2394-4722.2020.57 Page 9 of 9

with disease activity in patients with head and neck cancer. Clin Cancer Res 2017;23:4843-54.
31. Theodoraki MN, Hoffmann TK, Jackson EK, Whiteside TL. Exosomes in HNSCC plasma as surrogate markers of tumour progression
and immune competence. Clin Exp Immunol 2018;194:67-78.
32. Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer
cells. Nanomedicine 2016;12:655-64.
33. Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL. Isolation of biologically active and morphologically intact exosomes from
plasma of patients with cancer. J Extracell Vesicles 2016;5:29289.
34. Mignot G, Roux S, Thery C, Segura E, Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 2006;10:376-88.
35. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJP, et al. Sizing and phenotyping of cellular vesicles using nanoparticle
tracking analysis. Nanomedicine 2011;7:780-8.
36. Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of
nanoparticles and protein aggregates. Pharm Res 2010;27:796-810.
37. Gardiner C, Ferreira YJ, Dragovic RA, Redman CW, Sargent IL. Extracellular vesicle sizing and enumeration by nanoparticle tracking
analysis. J Extracell Vesicles 2013;2.
38. Oosthuyzen W, Sime NE, Ivy JR, Turtle EJ, Street JM, et al. Quantification of human urinary exosomes by nanoparticle tracking analysis.
J Physiol 2013;591:5833-42.
39. Koritzinsky EH, Street JM, Star RA, Yuen PS. Quantification of exosomes. J Cell Physiol 2017;232:1587-90.
40. Whiteside TL. The emerging role of plasma exosomes in diagnosis, prognosis and therapies of patients with cancer. Contemp Oncol (Pozn)
2018;22:38-40.
41. Hong CS, Sharma P, Yerneni SS, Simms P, Jackson EK, et al. Circulating exosomes carrying an immunosuppressive cargo interfere with
cellular immunotherapy in acute myeloid leukemia. Sci Rep 2017;7:14684.
42. Tang KD, Kenny L, Perry C, Frazer I, Punyadeera C. The overexpression of salivary cytokeratins as potential diagnostic biomarkers in
head and neck squamous cell carcinomas. Oncotarget 2017;8:72272-80.
43. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and
analysis. Cells 2019;8.
44. Campanella C, Caruso Bavisotto C, Logozzi M, Marino Gammazza A, et al. On the choice of the extracellular vesicles for therapeutic
purposes. Int J Mol Sci 2019;20.